Legacy Research Institute

Transforming medical care through science, technology, and innovation.

Robert M Kinast, MD

Robert M. Kinast, M.D.

Clinical Scientist, Legacy Research Institute
Associate Director, Glaucoma Fellowship, Legacy Devers Eye Institute
Clinical Associate Professor, OHSU Casey Eye Institute

Phone: 503-413-6453 | Email: rkinast@lhs.org

CV (updated Aug2025) | Peer reviewed publications
Devers Eye Institute | Legacy Health Provider Profile

Short Bio:

Dr. Kinast is Vice-Chair of Ophthalmology and a Clinician Scientist at the Legacy Devers Eye Institute. He invented the GentleDrop Eye Drop Guide, the iD2 eye drop adherence monitor, and a tube implant with magnetically controlled flow. His research has been NIH-funded for the past 10 years. He has served as an Investigator for the Clarifying the Optimal Application of SLT Therapy (COAST), Ocular Hypertension Treatment Study (OHTS), and STTR Phase I and SBIR Phase II studies. His research focuses include medication adherence, medical devices, selective laser trabeculoplasty, mitomycin compounding, and patient satisfaction. He is also the residency site director and associate glaucoma fellowship director at the Arthur Devers Memorial Clinic, which provides indigent ophthalmic care in Portland, OR.

He received his medical degree from the University of Michigan Inteflex Program (combined B.A./M.D. program) in Ann Arbor, followed by internship at the University of Pennsylvania in Philadelphia and residency at California Pacific Medical Center in San Francisco. He completed sub-specialty training in glaucoma at the Devers Eye Institute. Prior to medicine, Dr. Kinast studied the anthropology of religion at the University of Michigan and Oxford.

Research Interests:

Medical Devices
Medication adherence
Patient Satisfaction
Medication Compounding
Angle Closure Glaucoma

Publication Highlights:

Eye Drop Adherence with an Eye Drop Bottle Cap Monitor.
Kinast RM. Sanchez FG, Rees JP, Yeh K, Gardiner SK, Dawes J, Johnston ML, Porter JD, Klei V, Mansberger SL.
J Glaucoma. 2023 May 1;32(5):369-373.
https://pubmed.ncbi.nlm.nih.gov/37053080

Novel Eye Drop Delivery Aid Improves Outcomes and Satisfaction
Sanchez FG, Mansberger SL, Kung Y, Gardiner SK, Burgoyne CF, Cunningham Jr ET, Rees JP, Jones EP, Kinast RM.
Ophthalmol Glaucoma. 2021 Jan 12;S2589-4196(21)00011-9
https://pubmed.ncbi.nlm.nih.gov/33444854

Glaucoma Adherence - from Theriac to the future (Editorial).
Kinast RM and Mansberger SL.
American Journal of Ophthalmology. 2018 Jul: xiii-xv.
https://www.ncbi.nlm.nih.gov/pubmed/29716719

The degradation of mitomycin under various storage methods.
Kinast RM, Akula KK, Barker GD, DeBarber A, Whitson E, Mansberger SL. Journal of Glaucoma. 2016 Jun: 477-481.
https://www.ncbi.nlm.nih.gov/pubmed/26020687

Concentration Accuracy of Compounded Mitomycin C for Ophthalmic Surgery.
Kinast RM, Akula KK, Mansberger SL, Barker GD, Gardiner SK, Whitson E, DeBarber A. JAMA Ophthalmology. 2016 Feb: 191-195.
https://www.ncbi.nlm.nih.gov/pubmed/26661632

Menu